Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim resultsChristine D. Palmer, Karin Jooss, Benny Johnson et al.|Nature Medicine|2022Cited by 225